sedation and premed

Lecture Introduction

Speaker: Johanna, Senior Anesthetist
Topic: Pre-Medication Sedation
Audience Interaction: Engaged attendees through Menti meter for obtaining insight into their questions, aimed primarily at enhancing future lectures and encouraging active participation.

Learning Outcomes

Upon completion of the lecture, attendees should be able to:

  1. List and describe the various classes of anesthetic drugs employed for pre-medication and sedation, including their pharmacologic features.

  2. Understand comprehensively the effects, side effects, onset times, durations of action, and the various routes of administration for these drugs, fostering a deeper clinical understanding.

  3. Develop their own individualized pre-medication sedation protocol, tailoring it to specific procedural needs and patient factors.

Concept of Pre-Medication

  • Balanced Anesthesia: Pre-medication represents a critical initial phase preceding anesthesia induction, typically incorporating a combination of analgesic, sedative, and anxiolytic medications to optimize the patient's experience and surgical outcome.

  • The principal objectives of pre-medication include but are not limited to:

    • Relieving Fear and Anxiety: Aiding patients in managing anxiety-related preoperative stress which can lead to better outcomes.

    • Facilitating Smoother Induction: By utilizing pre-medication, the potency and dosage of induction and maintenance agents may be decreased, thus minimizing overall drug exposure and potential side effects.

    • Providing Analgesia and Muscle Relaxation: Key for invasive procedures to optimize patient comfort and cooperation.

    • Managing Autogenic Reflexes: Effectively preventing physiological responses such as bradycardia through pharmacological intervention.

Goals of Pre-Medication

  • Pain Management: Employing analgesic agents effectively to alleviate pain during and after painful procedures.

  • Patient Compliance: Reducing stress-induced hormone release to prevent potential catecholamine-induced cardiac arrhythmias, ensuring safer procedural conditions.

  • Optimal Dosing: Implementing strategies to decrease the need for higher doses of anesthetic agents, achieving clinical efficacy while prioritizing patient safety.

Overview of Pre-Medication Drugs

  1. Alpha-2 Agonists

    • Example: Dexmedetomidine

    • Utilization: These agents provide effective sedation and analgesia, mainly acting on central receptors to reduce central sympathetic outflow, leading to cardiovascular stability.

  2. Phenothiazines

    • Example: Acepromazine

    • Role: Primarily used for sedation, with additional anti-emetic and anti-arrhythmic properties; though primarily limited by a lack of analgesic effects.

  3. Benzodiazepines

    • Examples: Midazolam, Diazepam

    • Characteristics: These agents enhance the action of GABA, promoting anxiolysis and have anticonvulsant properties, making them suitable for a variety of patients.

  4. Opioids

    • Examples: Methadone, Butorphanol

    • Functionality: Primarily aimed at pain management, these drugs engage mu and kappa receptors to deliver profound analgesia, though they carry risks of respiratory depression.

  5. Anticholinergics

    • Usage: Rarely administered for pre-medication; however, they can be beneficial in emergency situations to manage bradycardia.

  6. Induction Agents

    • Utilization: Employed at reduced doses, agents such as Propofol and Ketamine can serve specific patient needs based on individual sedation requirements.

Focus on Acepromazine (Phenothiazine)

  • Effects: This drug results in sedation, anxiolysis, anti-emetic, anti-arrhythmic, and antihistaminic actions, providing wide-ranging benefits in maintaining patient calmness during procedures.

  • Limitations: Not effective for pain management; absence of analgesic properties necessitates cautious patient selection.

  • Mechanism of Action: Exhibits diverse receptor activity through dopamine antagonism, influencing serotonergic pathways, alongside minor effects on histamine and adrenergic receptors.

Side Effects:

  • Vasodilation: May lead to hypotension and potential incidents of syncope, necessitating careful monitoring during administration.

  • Respiratory Depression: There is an increased risk of respiratory depression when combined with opioid agents.

  • Variable Dosing Effects: Higher dosages can evoke extrapyramidal effects, including increased agitation and seizures.

Pharmacokinetics:

  • Properties: Demonstrating high protein binding and lipophilicity, Acepromazine effectively crosses the blood-brain barrier as well as the placenta.

  • Metabolism: Characterized by slow hepatic clearance leading to prolonged effects, requiring vigilance in administration.

  • Duration: Initial effects noticeable within 15-30 minutes, with action waning in 3-4 hours, remaining effective for up to 6-8 hours.

  • Dosage: Requires higher dosages in cats versus dogs due to metabolic differences.

Patient Considerations:

  • Suitability: Effective for healthy young adults across species—dogs, cats, horses. Caution is essential for individuals with:-

    • Non-corrected hypovolemia

    • Severe renal or liver impairment

    • Hypertrophic cardiomyopathy, which may exacerbate underlying conditions.

Focus on Alpha-2 Agonists

  • Examples:

    • Small Animals: Dexmedetomidine, Medetomidine

    • Equine: Xylazine, Detomidine, Romifidine

    • Human Drug: Dexmedetomidine, integrated formulations like Xenalpha (metatomidine + Patinoxan).

Mechanism of Action:

  • These agonists activate receptors in both the central nervous system (CNS) and peripheral tissues, inducing profound sedation with accompanying analgesia and muscle relaxation.

Side Effects:

  • Risks of cardiovascular depression (e.g., bradycardia, hypotension) remain due to pronounced sympatholytic effects of these drugs.

  • While respiratory effects are minimal, there is a notable concern for exacerbation when opioids are concurrently administered.

Patient Considerations:

  • Predominantly suitable for young, healthy dogs, cats, and horses. Use with extreme caution in patients exhibiting:

    • Severe cardiovascular compromise

    • Respiratory disorders

    • Diabetes mellitus, due to potential metabolic instability.

Focus on Benzodiazepines

  • Examples: Midazolam, Diazepam

  • Mechanism of Action: These act by enhancing GABA-receptor mediation, leading to increased neuronal inhibition promoting anxiolysis and preventative seizure measures.

  • Characteristics: Minimal adverse impacts on cardiovascular and respiratory functions; beneficial for compromised patients across age groups or health statuses.

  • Limitations: Generally less effective as sedatives in otherwise healthy patients compared to suspected or geriatric individuals.

Important Notes:

  • Midazolam: Exhibits a unique chemical architecture that allows versatile absorption through multiple routes, including intravenous and intranasal.

  • Diazepam: Usage constraints arise from high lipid solubility, limiting its applications in practice.

  • Antagonist Availability: Flumazenil can be employed as a reversal agent, though it incurs higher costs and clinical implications warrant diligence.

Focus on Opioids

  • Key Drugs: Methadone, Morphine, Butorphanol, Buprenorphine (These are controlled substances due to federal regulations and require careful handling).

  • Mechanism of Action: Act primarily on mu and kappa receptors, delivering potent analgesic effects alongside mild sedation.

Side Effects:

  • While efficacious for analgesia, these agents manifest significant risks for respiratory depression, nausea, and constipation, necessitating careful monitoring of patients’ responses.

Patient Considerations:

  • Indicated for any procedure necessitating rigorous pain control, yet utilize caution in patients with:

    • Pre-existing respiratory impairments

    • Conditions resulting in laryngeal dysfunction.

  • Reversal Agent: Naloxone may be utilized to counteract detrimental effects swiftly.

Other Drugs in Practice

  1. Anticholinergics: Infrequently used for pre-medication, but beneficial in emergency scenarios (e.g., Atropine) for cardiac stabilization and salivation control.

  2. Induction Agents: Can serve as sedative adjuncts in certain cases; agents like Ketamine and Propofol should be evaluated based on the type of case and required sedation depth.

Summary of Considerations for Pre-Medication Protocol

  • Thoroughly assess patient-specific factors such as age, health status, and temperament, tailoring pre-medication protocols accordingly.

  • Employ combinations of drugs to achieve optimal synergistic effects, effectively managing both desired and unwanted side effects.

  • Final Consideration: Careful documentation of which pharmacological options to combine based on procedural expectations and patient profiles.

Conclusion

  • Establish protocols considering diverse factors, including age, health status, and the procedure type.

  • Continuously evaluate the need for reversal agents in anticipation of the expected duration of the surgical or procedural intervention.

  • Questions: Attendees are strongly encouraged to reach out for clarifications or further information regarding any aspect of the material presented to ensure understanding and application in clinical practice.